ArticleProceedings of the National Academy of Sciences of the United States of America2024
Aerosolization of viable
Abstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Survival of the driest.Nature microbiology · 2026Article
- The host immune response to Mycobacterium tuberculosis determining protection or disease progression.Nature immunology · 2026Review
- The role of medical imaging in translational research into early pulmonary tuberculosis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026Review
- Bedaquiline and linezolid resistance in people with rifampicin-resistant tuberculosis in the Western Cape Province of South Africa.Research square · 2026Article
- Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study.The Lancet. Microbe · 2026Article
- A co-evolutionary perspective on humans andeLife · 2026Review
- Reducing spatial clustering to prevent tuberculosis transmission in a busy Zambian hospital: a modelling study based on person movements, environmental and clinical data.medRxiv : the preprint server for health sciences · 2025Article
- Detection of AerosolizedOpen forum infectious diseases · 2025Article
- AveloMask, a novel breath aerosol collection kit for airborneJournal of clinical microbiology · 2025Article
- Quantification of tuberculosis exposure in a high-burdened setting.Scientific reports · 2025Article
- A cytoderm metabolic labeling TPAPy-Tre for real-time detection of vitality ofMicrobiology spectrum · 2025Article
- Prominence of Mycobacterium tuberculosis biomarkers among sputum culture-negative clinic attendees, independent of Ultra status.Journal of infection and public health · 2025Article
- Strategies for shortening tuberculosis therapy.Nature medicine · 2025Review
- Exploiting thioether reactivity to label mycobacterial glycans.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Candidate transmission survival genome ofProceedings of the National Academy of Sciences of the United States of America · 2025Article
- Tuberculosis: An Update for the Clinician.Respirology (Carlton, Vic.) · 2025Review
- Estimating Mycobacterium tuberculosis transmission in a South African clinic: Spatiotemporal model based on person movements.PLoS computational biology · 2025Article
- PersistentiScience · 2024Article
- Reply to "Public health action · 2024Article
- Mycobacterium tuberculosis cough aerosol culture status associates with host characteristics and inflammatory profiles.Nature communications · 2024Article
Corrections and comments
- Commented on by
Authors and funding
14 authors.
Benjamin Patterson *Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam 1105, The Netherlands.ORCID 0000-0002-2445-6390
Ryan Dinkele *South African Medical Research Council, National Health Laboratory Service, University of Cape Town Molecular Mycobacteriology Research Unit & Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0001-6456-7530
Sophia GessnerSouth African Medical Research Council, National Health Laboratory Service, University of Cape Town Molecular Mycobacteriology Research Unit & Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
Anastasia KochSouth African Medical Research Council, National Health Laboratory Service, University of Cape Town Molecular Mycobacteriology Research Unit & Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0002-5897-4196
Zeenat HoosenAerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.ORCID 0009-0004-6770-304X
Vanessa JanuaryAerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.
Bryan LeonardAerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.
Andrea McKerryAerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.
Ronnett SeldonAerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.
Andiswa VaziAerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.
Sabine HermansAmsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam 1105, The Netherlands.ORCID 0000-0001-5146-2932
Frank CobelensAmsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam 1105, The Netherlands.ORCID 0000-0002-4367-1133
Digby F WarnerSouth African Medical Research Council, National Health Laboratory Service, University of Cape Town Molecular Mycobacteriology Research Unit & Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0002-4146-0930
Robin WoodInstitute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0002-4276-7117
Funding
Study of M. tuberculosis under human host selection to identify virulence and barrier lipids (Project 1)U19AI162584 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2021 to 2025
$13.5MIdentifying TB transmitters in high TB/HIV burdened communitiesR01AI147347 · NIAID · DESMOND TUTU HIV FOUNDATION · PI WOOD, ROBIN · 2019 to 2023
$4.0MNIAID NIH HHS R01 AI147347NIAID NIH HHS U19 AI162584
Abstract
Potential
Indexed as
BacillusMycobacterium tuberculosisTuberculosisTuberculosis, PulmonaryBacillotaHumansSensitivity and SpecificitySputumaerosol samplingsubclinicaltuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.